| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.0B | $11.2B | $10.2B | $8.8B | $5.8B | $4.3B | $9.5B | $8.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.7B | $2.4B | $2.2B | $2.1B | $1.0B | $-0.2B | $0.3B | $0.4B |
| Net Income | $1.5B | $1.5B | $1.1B | $1.3B | $0.4B | $-0.2B | $0.2B | $0.2B |
| EPS (Basic) | $6.18 | $6.20 | $4.36 | $4.56 | $1.47 | $-0.81 | $0.62 | $0.76 |
| EPS (Diluted) | $6.12 | $6.14 | $4.33 | $4.53 | $1.46 | $-0.80 | $0.61 | $0.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.8B | $16.5B | $15.4B | $15.5B | $15.4B | $16.8B | $15.0B | $14.0B |
| Current Assets | $3.0B | $3.3B | $2.6B | $2.9B | $2.9B | $4.2B | $2.1B | $2.0B |
| Cash & Equivalents | $0.9B | $1.3B | $0.8B | $1.2B | $1.4B | $3.2B | $0.5B | $0.4B |
| Total Liabilities | $22.1B | $20.2B | $17.7B | $16.6B | $16.3B | $18.2B | $15.4B | $13.4B |
| Current Liabilities | $4.5B | $4.7B | $3.7B | $3.4B | $3.0B | $2.4B | $2.9B | $2.6B |
| Stockholders' Equity | $-5.4B | $-3.7B | $-2.4B | $-1.1B | $-0.8B | $-1.5B | $-0.5B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $2.0B | $1.9B | $1.7B | $0.1B | $0.7B | $1.4B | $1.3B |
| Investing Cash Flow | $-0.2B | $-0.4B | $-0.3B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $-2.3B | $-1.0B | $-2.0B | $-1.8B | $-1.8B | $2.0B | $-1.1B | $-1.3B |